Our Partners
![](http://thepharmatimes.in/wp-content/uploads/2020/04/The-SME-Times_400-x-270.jpg)
![](http://thepharmatimes.in/wp-content/uploads/2020/04/The-Retail-Times_400-x-270.jpg)
![](http://thepharmatimes.in/wp-content/uploads/2020/04/The-Property-Times_400-x-270.jpg)
![](http://thepharmatimes.in/wp-content/uploads/2020/04/The-Power-Times_400-x-270.jpg)
![](http://thepharmatimes.in/wp-content/uploads/2020/04/The-Pharma-Times_400-x-270.jpg)
![](http://thepharmatimes.in/wp-content/uploads/2020/04/The-Hotel-Times_400-x-270.jpg)
![](http://thepharmatimes.in/wp-content/uploads/2020/04/The-Dairy-Times_400-x-270.jpg)
![](http://thepharmatimes.in/wp-content/uploads/2020/04/The-Automobile-Times_400-x-270.jpg)
Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.
Mumbai, Maharashtra, India, Monday, April 22, 2013 -- (Business Wire India) -- 'The Illustrated Guide to Living with Diabetes in India', a practical guide to self-manage diabetes was launched at Kochi on Friday, April 19, 2013 by Sir Michael Hirst, President, International Diabetes Federation (IDF) during the 5 th World Congress of DiabetesIndia. Dr. Shaukat Sadikot, President - Elect, IDF and Prof. Dr. Jean Claude Mbanya, Past-President, IDF was also present during this occasion. The book authored by The Living with Diabetes in India (LWDI), an online community for people with diabetes with over half a million members - and co-published in India by Popular Prakashan, is now available at leading book stores across India and through online retailers.